X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Torrent Pharma with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TORRENT PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

TORRENT PHARMA    Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 TORRENT PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    TORRENT PHARMA
Mar-17
ADCOCK INGRAM
Jun-14
TORRENT PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs1,768376-   
Low Rs1,186271-   
Sales per share (Unadj.) Rs346.1111.7-  
Earnings per share (Unadj.) Rs55.2-28.1-  
Cash flow per share (Unadj.) Rs73.3-23.3-  
Dividends per share (Unadj.) Rs14.000-  
Dividend yield (eoy) %0.90-  
Book value per share (Unadj.) Rs257.187.7-  
Shares outstanding (eoy) m169.22168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.32.9 147.5%   
Avg P/E ratio x26.8-11.5 -233.1%  
P/CF ratio (eoy) x20.1-13.9 -145.4%  
Price / Book Value ratio x5.73.7 155.8%  
Dividend payout %25.40-   
Avg Mkt Cap Rs m249,88754,555 458.0%   
No. of employees `00011.84.3 274.4%   
Total wages/salary Rs m9,9343,424 290.1%   
Avg. sales/employee Rs Th4,971.54,392.1 113.2%   
Avg. wages/employee Rs Th843.2797.6 105.7%   
Avg. net profit/employee Rs Th792.4-1,106.7 -71.6%   
INCOME DATA
Net Sales Rs m58,56918,855 310.6%  
Other income Rs m2,233132 1,691.2%   
Total revenues Rs m60,80218,987 320.2%   
Gross profit Rs m13,773-3,267 -421.5%  
Depreciation Rs m3,069814 377.2%   
Interest Rs m2,056511 402.5%   
Profit before tax Rs m10,881-4,460 -244.0%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,545279 554.4%   
Profit after tax Rs m9,336-4,751 -196.5%  
Gross profit margin %23.5-17.3 -135.7%  
Effective tax rate %14.2-6.2 -227.3%   
Net profit margin %15.9-25.2 -63.3%  
BALANCE SHEET DATA
Current assets Rs m53,84113,810 389.9%   
Current liabilities Rs m31,6127,770 406.8%   
Net working cap to sales %38.032.0 118.5%  
Current ratio x1.71.8 95.8%  
Inventory Days Days97111 87.6%  
Debtors Days Days84124 67.6%  
Net fixed assets Rs m42,0798,050 522.7%   
Share capital Rs m84688 966.6%   
"Free" reserves Rs m42,6550-   
Net worth Rs m43,50114,799 293.9%   
Long term debt Rs m22,4085,201 430.9%   
Total assets Rs m101,25027,957 362.2%  
Interest coverage x6.3-7.7 -81.4%   
Debt to equity ratio x0.50.4 146.6%  
Sales to assets ratio x0.60.7 85.8%   
Return on assets %11.3-15.2 -74.2%  
Return on equity %21.5-32.1 -66.8%  
Return on capital %19.6-19.8 -99.1%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m14,7620-   
CASH FLOW
From Operations Rs m10,1271,609 629.2%  
From Investments Rs m-7,869-494 1,592.4%  
From Financial Activity Rs m-1,9184,720 -40.6%  
Net Cashflow Rs m2125,835 3.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.18 Rs / ZAR

Compare TORRENT PHARMA With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare TORRENT PHARMA With: AJANTA PHARMA  SUN PHARMA  ORCHID PHARMA LTD  UNICHEM LAB  AUROBINDO PHARMA  



Today's Market

Sensex Opens Marginally Higher; Infosys & ICICI Bank Top Gainers(09:30 am)

Asian stock markets are lower today as Japanese and Hong Kong shares fall. The Nikkei 225 is off 0.5% while the Hang Seng is also down 0.5%.

Related Views On News

TORRENT PHARMA Announces Quarterly Results (4QFY18); Net Profit Up 10.7% (Quarterly Result Update)

Jun 1, 2018 | Updated on Jun 1, 2018

For the quarter ended March 2018, TORRENT PHARMA has posted a net profit of Rs 2 bn (up 10.7% YoY). Sales on the other hand came in at Rs 17 bn (up 20.1% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

How to Avoid a 90% Loss Suffered by This Super Investor(The 5 Minute Wrapup)

Jul 12, 2018

Blindly following super investors is a dangerous game to play. Here's how you can avoid such mistakes.

The Answer to Your Wealth Worries: Small Caps (Especially Now)(Profit Hunter)

Jul 10, 2018

If you're worried about the markets - you are on the wrong track. This is opportunity - put your wealth-building hat on, instead - Richa shows you how...

The Multiple Problems with the Minimum Support Price (MSP) System(Vivek Kaul's Diary)

Jul 11, 2018

The price signals that MSP sends out, creates its own set of problems.

ICICI Pru Mutual Fund Tarakki Karega! - The Unethical Way?(Outside View)

Jul 11, 2018

PersonalFN explains how ICICI Prudential Mutual Fund flouted the norms of related party transactions while subscribing to the IPO of ICICI Securities.

PPF v/s Mutual Funds: Which Is Better?(Outside View)

Jul 10, 2018

PersonalFN highlights the key points of distinction between PPF and mutual funds.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TORRENT PHARMA SHARE PRICE


Jul 20, 2018 10:09 AM

TRACK TORRENT PHARMA

  • Track your investment in TORRENT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TORRENT PHARMA

TORRENT PHARMA - SHASUN PHARMA COMPARISON

COMPARE TORRENT PHARMA WITH

MARKET STATS